Oral Solid Dosage Pharmaceutical Formulation Market: Global Market Size, Dynamics, Regional Share, Trends, Competitor Analysis 2016 to 2021 and Forecast 2022 to 2028

$ PRICE - $ 3,000.00$ 8,900.00

Global Oral Solid Dosage Pharmaceutical Formulation Market By Product Type (Tablets, Lozenges, Capsules), By Drug Release Mechanism (Sustained Release, Extended Release, Instant Release, Chewable Tablets, Effervescent Tablets, Enteric Release), By Disease Indication (Asthma, Chronic Obstructive Pulmonary Disease (COPD), Pulmonary Arterial Hypertension, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Drug Stores, Online Pharmacies), and Geography

 

$ PRICE - $ 3,000.00$ 8,900.00
Clear selection
Clear
$ PRICE - $ 3,000.00$ 8,900.00
FacebookTwitterLinkedinEmail

Report

Description

The Oral Solid Dosage Pharmaceutical Formulation Market was valued at US$ 493.3 Bn in 2021 and is anticipated to grow at US$ 926.6 Bn till 2028 recording a CAGR of 6.6% during the forecast period 2022-2028. Oral solid dosage pharmaceutical formulation are most widely used dosage forms. They are easy to manufacture and transport due to their increased chemical and physical stability. Oral Solid Dosage Pharmaceutical Formulation Market are cost effective when compared with the other kind of dosage forms. These can be formulated in various flavors in order to mask the unpleasant taste of the formulation and increase the patient compliance. The technological advancements are enabling the manufacturers to formulate new drugs such as sustained release dosage forms which minimize the frequent administration of the drug. The most often utilised medications to treat various medical problems are oral solid dose forms. In comparison to other dosage forms, oral solid dosage forms are both cost-effective and simple to manufacture. They provide manufacturers with numerous advantages, including trouble-free packaging and transportation, as well as greater chemical and physical stability. Patients can benefit from oral solids as well. Patients frequently choose oral solid dosage forms because of the inherent advantages in dosage administration and the absence of the need for dose measurement. In order to improve patient compliance, they can be made in a variety of flavours and dose formats. Few APIs, for example, have a disagreeable taste, thus they are made in the form of effervescent tablets to ensure patient acceptability and compliance.


Oral Solid Dosage Pharmaceutical Formulation Market

MARKET SUMMARY
-
6.6%
  • Study Period– 2021-2027
  • Base Year– 2020
  • CAGR– 6.6%
  • Largest Market– North America
  • Fastest Growing Market– Asia-Pacific

Oral Solid Dosage Pharmaceutical Formulation

  • Oral Solid Dosage Pharmaceutical Formulation Market gives historical, current, and future market sizes (US$ Bn) of product type and distribution channel and geographic regions.
  • This report studies market dynamics elaborately to identify the current trends & drivers, future opportunities and possible challenges to the key stakeholders operating in the market.
  • In addition, the market report includes regulatory scenario, and competition analysis with vividly illustrated the competition dashboard to assess the market competition.
  • Moreover, PBI analyzed the market to better equip clients with possible investment opportunities across the regions (Regional Investment Hot-Spots) and market unmet needs (Product Opportunities).
  • Key stakeholders of the market report include suppliers, manufacturers, marketers, policy makers engaged in manufacturing and supply of Infant nutrition
Market Key Players
  • AstraZeneca Plc.
  • Bristol-Myers Squibb Company
  • Novartis AG
  • Pfizer Inc.
  • AbbVie Inc.
  • Boehringer Ingelheim GmbH
  • Johnson & Johnson
  • Merck & Co. Inc.
  • Gilead Sciences
Growth

Oral Solid Dosage Pharmaceutical Formulation Market

Market players are majorly focused on oral solid dosage forms due to convenience and safe way of administration. Increased sedentary and fast paced lifestyle is leading to adopt lifestyle related diseases such as obesity, diabetes. The manufacturers are targeting the population in developing countries in order to enhance the market. A significant boost is observed in the Asia Pacific region owing to increased population. Moreover, the generic manufacturers are playing a major role in the growth of the oral solid dosage pharmaceutical formulation market by introducing generic drugs in the local market. However, the high regulatory requirement is expected to hamper the market.


North-America Got Significant Share

Oral Solid Dosage Pharmaceutical Formulation Market

Geographically, global oral solid dosage pharmaceutical formulation market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. North America dominates the oral solid dosage pharmaceutical formulation market and expected to grow at significant CAGR over the forecasted period. North America being more lucrative showing the higher expectancy of market growth. Asia Pacific oral solid dosage pharmaceutical formulation market is expected to show higher growth rate. The emerging countries such as India and China are showing a significant growth due to the entry of local market players which formulate the generic drugs.

Latin America
Latin-America
North-America
North-America
Europe
Europe
Asia Pacific
Asia-Pacific
Middle East
Middle East

Key

Key Features of the Report

  • The report provides granular level information about the market size, regional market share, historic market (2016 to 2021) and forecast (2022 to 2028)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startup’s details that are actively working in the market
  • The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
  • The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market

Key

Notable Market Developments

Oral Solid Dosage Pharmaceutical Formulation Market Segmentation


Location

GEOGRAPHY


Report

Table Of Content


Report

Company Profile

  • AstraZeneca Plc. (UK)
  • Bristol-Myers Squibb Company (U.S)
  • Novartis AG (Switzerland)
  • Pfizer Inc. (U.S)
  • AbbVie Inc. (U.S)
  • Boehringer Ingelheim GmbH (Germany)
  • Johnson & Johnson (U.S)
  • Merck & Co. Inc. (U.S)
  • Gilead Sciences (U.S)

Description

The Oral Solid Dosage Pharmaceutical Formulation Market was valued at US$ 493.3 Bn in 2021 and is anticipated to grow at US$ 926.6 Bn till 2028 recording a CAGR of 6.6% during the forecast period 2022-2028. Oral solid dosage pharmaceutical formulation are most widely used dosage forms. They are easy to manufacture and transport due to their increased chemical and physical stability. Oral Solid Dosage Pharmaceutical Formulation Market are cost effective when compared with the other kind of dosage forms. These can be formulated in various flavors in order to mask the unpleasant taste of the formulation and increase the patient compliance. The technological advancements are enabling the manufacturers to formulate new drugs such as sustained release dosage forms which minimize the frequent administration of the drug. The most often utilised medications to treat various medical problems are oral solid dose forms. In comparison to other dosage forms, oral solid dosage forms are both cost-effective and simple to manufacture. They provide manufacturers with numerous advantages, including trouble-free packaging and transportation, as well as greater chemical and physical stability. Patients can benefit from oral solids as well. Patients frequently choose oral solid dosage forms because of the inherent advantages in dosage administration and the absence of the need for dose measurement. In order to improve patient compliance, they can be made in a variety of flavours and dose formats. Few APIs, for example, have a disagreeable taste, thus they are made in the form of effervescent tablets to ensure patient acceptability and compliance.

ASIA PACIFIC OFFICE

Precision Business Insights, 5th Floor, Mohan’s Elite, Opp : Bharat Petroleum Pump, Khanamet Road, Hitech City, Hyderabad – 500084

EUROPE OFFICE

Precision Business Insights, Kemp House, 152 – 160 City Road, London EC1V 2NX